C. Creasy

发表

Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma.

Eytan Ruppin, Nir Friedman, Dan Reshef, 2018, Cancer discovery.

IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation

F. Marincola, C. Liu, P. Hwu, 2016, Cancer Immunology Research.

SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity

Kyle R Jackson, P. Hwu, S. Woodman, 2017, Cancer Immunology Research.

Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.

R. Beroukhim, L. Garraway, C. Stewart, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016, Journal for ImmunoTherapy of Cancer.

Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma

Young Uk Kim, R. Amaria, S. Patel, 2018, Journal of immunotherapy.

PD-L1 expression and prognostic impact in glioblastoma.

G. Fuller, G. Calin, Shouhao Zhou, 2016, Neuro-oncology.

Multi-modal molecular programs regulate melanoma cell state

P. A. Futreal, M. Morgan, A. G. Robertson, 2022, Nature Communications.

Exposure to anti‐PD‐1 causes functional differences in tumor‐infiltrating lymphocytes in rare solid tumors

Gopal Singh, F. Meric-Bernstam, A. Naing, 2019, European journal of immunology.

Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy Resistance

Jared C Malke, Manolis Kellis, J. Wargo, 2022, bioRxiv.

Metabolic plasticity of T-cell therapies: multi-omic profiling of interacting human tumor-infiltrating lymphocytes and autologous tumor adoptive cell therapy

Jonathan L. Robinson, R. Amaria, P. Hwu, 2022, bioRxiv.

Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade

P. Brown, P. Sharma, P. Hwu, 2017, Cancer Immunology Research.

Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy.

R. Davis, L. Garraway, Jing Wang, 2018, Cell metabolism.

Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.

J. McQuade, J. Wargo, A. Lazar, 2016, Cancer discovery.

Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy

K. Tomczak, A. Lazar, S. Woodman, 2021, Cell reports.

Bivalent and Broad Chromatin Domains Regulate Pro-metastatic Drivers in Melanoma

K. Tomczak, A. Lazar, S. Woodman, 2019, bioRxiv.

Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome

Young Uk Kim, Jeffrey E. Lee, R. Beroukhim, 2018, Clinical Cancer Research.

Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy

K. Rajapakshe, C. Coarfa, M. Hurwitz, 2020, Nature Communications.

Clinical Success of Adoptive Cell Transfer Therapy Using Tumor Infiltrating Lymphocytes

P. Hwu, C. Bernatchez, J. Chen, 2015 .

Manipulating the Tumor Microenvironment Ex Vivo for Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy

P. Hwu, J. Weber, A. Sarnaik, 2014, Clinical Cancer Research.

Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues

I. Wistuba, A. Tsao, A. Vaporciyan, 2021, Scientific Reports.

4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer

Young Uk Kim, A. Maitra, P. Hwu, 2017, Clinical Cancer Research.

Human genome meeting 2016

Kumar Kshitij Patel, A. Pang, W. Chung, 2016, Human Genomics.

Thoracic and abdominal lymphatic pump techniques inhibit the growth of S. pneumoniae bacteria in the lungs of rats.

C. Creasy, Lisa Hodge, Artur Schander, 2013, Lymphatic research and biology.

Human genome meeting 2016

A. Pang, W. Chung, J. Lupski, 2016, Human Genomics.

Predictive immune biomarker signatures in the tumor microenvironment of melanoma metastases associated with tumor-infiltrating lymphocyte (TIL) therapy

R. Davis, P. Hwu, Wencai Ma, 2014, Journal of Immunotherapy for Cancer.

Lymphatic Pump Treatment as an Adjunct to Antibiotics for Pneumonia in a Rat Model

H. King, C. Creasy, Lisa Hodge, 2015, The Journal of the American Osteopathic Association.

PD-L1 expression and prognostic impact in glioblastoma.

G. Fuller, G. Calin, Shouhao Zhou, 2016, Neuro-oncology.

Human genome meeting 2016

Kumar Kshitij Patel, Jose Maria Gonzalez-Izarzugaza, A. Pang, 2016, Human Genomics.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.

J. McQuade, J. Wargo, A. Lazar, 2016, Cancer discovery.

Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy

K. Tomczak, A. Lazar, S. Woodman, 2021, Cell reports.